The JUMISC gears the development of its activities towards serving society. Therefore, in addition to the direct benefits derived from an adequate education and the training of health professionals through technological dissemination, R & D also generates extraordinary achievements of social interest, contributing to increased knowledge and use of technology related to minimally invasive surgery and other fields of health. Among the various lines of work proposed by RDI public groups and private Centre users specifically relate to:

• New types of sutures for paediatric patients, allowing the longitudinal and transverse growth of vessels during the growth phase, as well as the advantage simple and quick application.
• Research for the treatment of morbid obesity, still in the pilot phase, involving the implantation of a laparoscopic electrostimulator, which emits pulses, resulting in a decrease in food consumption and therefore weight. In the future this would represent a new therapeutic option for obese patients, being reversible, less invasive and a short operative time.
• Valuation of the osseointegration ability of different biomaterials for orthopaedics and traumatology.
• Development of navigation systems and surgical planning, based on virtual reality simulators and simulations aimed at optimising the physical learning period of minimally invasive surgery.
• Evaluation and development of new types of stents in the treatment of ureteral strictures.
• Rating aortic clamping times on haemodynamic variables in replacement aortic laparoscopic surgery and conventional monitoring of the autonomic nervous system; paediatric ventilation, and building a compartment syndrome model.
• Surgical simulation, virtual reality and usage of medical imaging, employing the latest technological advances for the training of qualified surgical professionals, allowing earlier training in surgical intervention, in anticipation of potential unpredictable events.
• Development of new materials, instruments, equipment and surgical protocols, etc.
• Experimental modelling of different pathologies (aortic aneurysm, prostate disease, acute and chronic myocardial infarction, etc.).
• Application of gene therapy in the treatment of chronic myocardial ischaemia.